Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Jan 25 | ARDX Ardelyx | Common Stock | Buy | Acquire P | No | No | 4.9883 | 199,000 | 992.67 k | 1,937,765 |
26 Dec 24 | ARDX Ardelyx | Common Stock | Option exercise | Acquire M | No | No | 0.55 | 100,000 | 55.00 k | 1,738,765 |
26 Dec 24 | ARDX Ardelyx | Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.55 | 100,000 | 55.00 k | 0 |
19 Dec 24 | ARDX Ardelyx | Common Stock | Buy | Acquire P | No | No | 4.6722 | 213,300 | 996.58 k | 1,638,765 |
13 Nov 24 | ARDX Ardelyx | Common Stock | Buy | Acquire P | No | No | 4.6167 | 215,868 | 996.60 k | 1,425,465 |
1 Jul 24 | ADAP Adaptimmune Therapeutics | Option to purchase Ordinary Shares Ordinary Shares | Grant | Acquire A | No | No | 0.16 | 1,583,214 | 253.31 k | 1,583,214 |